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Abstract
Background: Overweight is considered an important risk factor for diseases in the context of metabolic syndrome.
Lifestyle modifications are the means of choice to reduce weight in persons with a Body Mass Index of 28 to 35.
The study examines whether there are any differences between two intervention strategies regarding weight
reduction in overweight persons.
Methods/Design: The study is a multicentre randomized controlled trial with observation duration of 12 months.
Eight study centres are involved to include a minimal sample size of 150 participants. Randomization ratio is 2:1.
Feasible persons are checked according to inclusion and exclusion criteria and after given informed consent are
assigned randomly to one of two intervention programs: A) intervention group: comprehensive lifestyle
modification program (Individual Health Management IHM) with 3 months reduction phase plus 9 months
maintaining phase, B) control group: written information with advice for healthy food habits (Usual care UC).
Participants of the IHM group have access to a web-based health portal and join 3 full-day and 10 two-hour
training sessions during the first 3 months. During the remaining 9 months four refresh trainings will be performed.
There are 3 different diet strategies (fasting, two-day diet, meal replacement) for free choice. Participants of the
control group are provided with acknowledged rules for healthy food according to the German Nutrition Society
(DGE). Examinations are conducted at baseline, after 3, 6, 9 and 12 months. They include body weight, waist
circumference, blood pressure, laboratory findings and a bio-impedance analysis to measure body composition.
Statistical analysis of the primary outcome ‘change of body weight after 12 months’ is based on ITT population
including analysis of variance of the weight differences between month 0 and 12 with the factors ‘group’, ‘baseline
value’ and ‘study centre’. Secondary outcomes will be analyzed exploratively.
Discussion: The monitoring of the study will implement different measures to enhance compliance, avoid attrition
and ensure data quality. Based on a blended learning concept and using web-based e-health tools the program
promises to achieve sustainable effects in weight reduction.
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Background
There is an increasing trend for overweight and obesity
worldwide. In 2008, 35 % of adults aged 20+ were over-
weight (BMI ≥ 25 kg/m2). The worldwide prevalence of
obesity has nearly doubled between 1980 and 2008 [1]. In
a more recent analysis this trend has been confirmed [2].
In developed countries like US the figures are markedly
higher. Approximately two thirds of adults are overweight
(BMI of 25-29.9) or obese (BMI ≥ 30) [3]. The German
Health Interview and Examination Survey for Adults
(DEGS1), conducted from 2008 through 2011, provides
current data about overweight and obesity among adults
in Germany based on a representative sample of 7116
persons [4]. Prevalence of overweight defined as BMI ≥ 25
is 53 % for females and 67 % for males with increasing
rates in higher age groups. While prevalence of obesity
grade I (BMI 30-35) is similar in both sexes (16 % in
women, 18 % in men) pre-adipositas (BMI 25–30) is more
frequent in men (44 %) than in women (29 %).
Obesity is associated with many comorbid conditions
which has major implications for longevity, quality of life
and healthcare costs [5]. It could be shown that a strong
and linear association exists between Body-Mass-Index
(BMI > 20) and the risk of developing type 2 diabetes,
hypertension, CVD, and other chronic diseases in both
men and women [6].
Therapeutic interventions aiming at weight reduction
range from multiple modalities including behavioural
therapy and pharmacotherapy integrating clinical and
community approaches [7] to lifestyle counselling and
mere nutritional programs. Enhanced lifestyle counselling
proved to be superior to usual care with respect to weight
reduction [8]. Compared to minimal or no intervention it
could be shown that self-management plus exercise pre-
vented weight increase in patients with cardiometabolic
disease [9]. A systematic review comparing the effects of
different popular diets revealed that only weight-watchers
program was beneficial to usual care in RCTs of 12 month
duration [10].
From the findings in the literature one has to conclude
that a sustainably successful treatment of overweight
requires intensive education, counselling, multiple re-
sources, and ongoing support. The Individual Health
Management (IHM) is a program which meets these pre-
requisites. It is theory driven and designed to promote
changes across multiple health behaviours simultaneously
aiming for participation of healthy and ill people to en-
hance their individual responsibility, self-determination
and health literacy [11]. Self-management supporting the
participants to optimize physiological skills and psycho-
social competencies is considered the core element of the
intervention. It comprises areas like physical activity,
nutrition, self-efficacy and social support. To enhance
sustainability they are to be trained and implemented into
daily activities. The lifestyle program combines a web-
based lifestyle modification program, physician-led coun-
selling via face-to-face or telemedicine visits and various
forms of group sessions to achieve behavioural change
(blended learning concept). To ensure a high standard of
professional service, IHM health staff graduates in a 200 h
theoretical and practical training in comprehensive life
style medicine.
Although the basic concept of IHM is very broad and
multifaceted the planned study will focus on weight
reduction as target parameter. Due to a comprehensive
change in lifestyle the effects are expected to be enduring.
Thus, the decisive measurement of body weight should be
one year after onset of the program. For weight monitor-
ing in overweight persons including obesity grade I it is
highly relevant to compare the effects of IHM with the
common brief diet and lifestyle counselling used in daily
routine of general practitioners. This is in line with the
findings of a systematic review of RCTs on multifactorial
lifestyle interventions in primary and secondary preven-
tion [12].
The study is part of a comprehensive network program
to install and maintain prevention programs for different
risk groups at selected spas in Bavaria. The project is to
contribute to the improvement of the medical quality of
health services offered in the spas.
The primary objective of the study is to examine
whether there are any differences between two interven-
tion strategies (Individual Health Management versus
usual care) regarding weight reduction at month 12 in
overweight persons. Further objectives are the compara-
tive analysis of secondary outcome parameters like Body-
Mass-Index, waist circumference, laboratory findings,
blood pressure and the ratio of fat, muscle mass and bod-
ily water. Moreover, the descriptive comparison of both
intervention groups include the analysis of the course of
changes in body weight, a responder/non-responder
analysis, and an analysis with respect to the applied dietary
strategy.
Methods/Design
Study design
The study is a multicentre randomized controlled
trial. The study duration for each participant is
12 months with five sequential examinations. It will
be performed in total in 8 study centres located in
different spa towns all over Bavaria, and complemen-
ted by the outpatient unit of the Competence Centre
for Complementary Medicine and Naturopathy at
Klinikum rechts der Isar, Munich. The centres in the
spas are affiliated to private practices of General
practitioners. These centres are committed to be a
part of the local core teams promoting Individual
Health Management (IHM) which are pooled into a
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centrally coordinated network of health promotion
called ‘IHM-Campus’.
Recruitment and participants
Measures for recruitment of feasible study participants
include different strategies which are not regulated
equally across all study centres. The methods consist of:
search in the databases of the GP practices, conduct of
local action days to attract population interested in over-
weight and prevention from diabetes, advertisements in
local media with the offer for obese persons to partici-
pate in a clinical study. All interested persons will con-
tact the local IHM teams which will provide basic
information around the study and a tool to screen for
the main inclusion criteria. All persons who apparently
should comply with the requirements of the study are
invited to a personal appointment with the trial phys-
ician to undergo a comprehensive examination of the
criteria for inclusion and exclusion. Potential partici-
pants will be informed on background, objectives, bene-
fit and risks of the study by a leaflet as well as orally by
the trial physician.
Inclusion/exclusion criteria
Persons of both sexes, aged 18 to 67 years, with moder-
ate overweight defined as Body-Mass-Index from 28.0 to
35.0, can be included to the study. A written informed
consent is mandatory.
Persons will not be included if one of the following
exclusion criteria are present: not legally competent,
insufficient skills in German language, no private ac-
cess to internet, already known pregnancy, known
psychiatric disease including eating disorder or addic-
tion, known diseases of the eyes, known diabetes type
1 or 2, hypertension grade II (systolic BP ≥ 160 mmHg
or diastolic BP ≥ 100 mmHg) with/without medication,
known heart disease, known gastric or duodenal ul-
cers, diseases of the liver or kidneys which do not
allow an increased intake of proteins, disease-related
impairments hampering certain elements of the lifestyle
program or therapeutic conditions not compatible with
lifestyle modifications.
Randomisation
Eligible participants will be randomized immediately
after formal inclusion to the study. The trial physician
will open the closed envelopes in strictly sequential
order of the enrollments and the allocated treatment
arm will be disclosed to the study participant. The
allocation ratio is 2:1, means 2 for IHM group and 1
for the comparison group. Randomisation and alloca-
tion envelopes will be prepared by an independent
data manager at the institute for medical statistics
and epidemiology at TU Munich.
Interventions
The study compares two intervention arms (IHM =
Individual Health Management; UC = Usual Care):
Group IHM: Lifestyle program ‘Individual Health
Management’ with an overall duration of 12 months is
composed of 2 phases: i) the first 3 months (reduction
phase) include 3 full-day so called’introduction days’
plus 10 two-hour weekly training sessions; ii) during
the following 9 months (maintaining phase) participants
are practicing lifestyle modifications by oneself supported
by 4 full-day refresh training sessions. The program
encompasses access to a web-based health portal
(https://www.viterio.de/) providing detailed advice and
instructions with respect to food, exercise and relaxation.
Furthermore, this tool allows a personalized feed-back
control of the progress made so far. IHM is implemented
as a group intervention program with a group size of
roughly 12. All training sessions will be performed
in the local study centres. Details of the intervention
concept and realization are described elsewhere [11]. All
participants will be offered three different diet strategies:
i) fasting (per week one regular day, five waiver days,
one food restriction day with < 900 kcal plus fasting
during week 7), ii) two-day diet (five regular days,
two serial food restriction days with < 600 kcal),
iii) meal replacement (one regular day, five waiver
days, one food restriction day with meal replacement
< 900 kcal plus meal replacement in week 7) for
free choice.
Group UC: This intervention is an active control
intervention reflecting the common practice in usual
care. Participants are provided with a leaflet containing
10 acknowledged rules for healthy food and physical
exercise according to the German Nutrition Society
(DGE). They will neither join the group sessions nor
will get access to the web-based health portal.
Figure 1 shows the basic design of the study with the
two treatment arms and all examinations.
Outcomes
The primary outcome measure to test the hypothesis of
no differences between the effects of both intervention
groups is change in body weight from baseline to month
12. Secondary outcome parameters are Body-Mass-Index,
waist circumference, blood pressure, heart frequency, la-
boratory findings, and distribution of bodily fat measured
by bio-impedance-analysis. The occurrence of adverse
events will be captured systematically at each physical
examination following the baseline testing. Weight reduc-
tion will also be analyzed by the frequency of responders
in both groups. A responder at month 12 will be defined
as a 7.5 % reduction of baseline body weight. The schedule
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for all examinations during the study is displayed in
Table 1.
Statistical analysis
Based on indications from the literature we assumed a
mean reduction for body weight after 12 months of 6 kg
under IHM and of 3 kg under usual care conditions.
Given a common standard deviation of 6 kg for the
change in weight the sample size for the t-test for
independent groups (α = 0.05, 2-sided, power 80 %) is es-
timated as 98 in one group and 49 in the second
(allocation ratio 2:1). Hence, the total sample size is 150
participants.
The confirmatory analysis will be conducted using a 2-
sided significance test at the 5 % significance level. Based
on the intent-to-treat population the primary outcome
(change in body weight Δmonth 0 – month 12) will be tested
by analysis of variance with the grouping factor ‘interven-
tion’ controlled for baseline value. The factor ‘study centre’
will also be included to the test model. In participants with
missing data for weight at month 12 (drop-outs) an ad-
equate conservative imputation technique will be applied.
Month
2
:
Screening 1
1 2 3 4 5
Control examinations
IHM
Reduction 
phase
UC UC UC UC
R
a
n
d
o
m
0 3 6 9 12
IHM
Maintaining
phase
Fig. 1 Flow chart showing the design of the study (IHM = Individual Health Management; UC = Usual Care)
Table 1 Study process chart
Month
Examination 0 3 6 9 12
Inclusion-/exclusion criteriaa X
Informed consenta X
Randomisation X
Sociodemographic data X
Size X
Weight, waist circumference, blood pressure, heart frequency X X X X X
Bio-Impedance-Analysis X X X X X
Laboratory findings:
Electrolytes (Ca, K, Cl, Mg, Na) X X
Liver enzymes (ASAT, ALAT, GGT, ALP, Bilirubin) X X
Kidney (Crea, Urea, Uric acid) X X
Blood count (Ery, Leuco, Ptl, Hk, Hb) X X
TSH (basal) X X
Fasten glucose X X X
Trigycerides X X X
Total cholesterol X X X
HDL-/LDL-Cholesterol X X X
Adverse events/effects X X X X
ato be checked before inclusion into study
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Secondary endpoints will be analyzed analogously but
using an explanatory approach. Hence, a correction of the
error probabilities due to multiple testing is not indicated.
These analyses will be performed on both intent-to-treat
and per-protocol populations. A responder analysis with
respect to the primary outcome will be performed using a
responder definition with a threshold of 7.5 % weight
reduction at month 12 compared to the baseline value.
Depending from the number of participants who chose
the different nutritional regimen a subgroup analysis
within the IHM group will be performed.
All captured data will be analyzed descriptively by ap-
propriate statistical parameters: absolute and relative
frequencies for categorical data and arithmetic means,
medians, standard deviations for numerical data. Where
indicated, 95 % confidence intervals will be presented.
Apart from the confirmatory analysis a series of sensitiv-
ity analyses will be performed to explore the impact of
different factors on the results of the analyses. Relevant
factors are among others adherence to the protocol,
adherence to the intervention program IHM and different
responder definitions.
Ethical review
Ethical approval for this study was obtained from the
ethical review board of the Medical faculty of TU Munich
(file number 97/14). The investigators will ensure that the
study will be conducted in compliance with the ethical
guidelines as set out by this committee, and in line with
the guidelines for good clinical practice (GCP).
Discussion
Quality assurance and bias
The protocol was developed according to the Consort
guidelines (see Additional files 1 and 2). All trial physi-
cians are qualified regarding the legal requirements ac-
cording the German Drug Law (AMG) and in line with
the guidelines for GCP and ICH. Staff members of the
study centres at the participating spas being involved in
coaching of the IHM group members are trained and
certified as health coaches.
The study will be monitored by a professional institu-
tion with acknowledged expertise in supervision of clinical
trials of all kinds (Munich Study Centre at the Medical
faculty of TUM). The monitoring plan comprises a central
indoor-monitoring as well as onsite visits at the participat-
ing study centres. The confirmatory analysis of the data is
conceptualized and will be performed by an independent
statistician at the institute for medical statistics and epi-
demiology at the TUM.
Although randomization should eliminate selection bias
there are some other issues with potential impact on the
conclusiveness of the study. First, we tried to avoid early
drop-outs by comprehensive information of the study.
Both intervention arms are introduced as strategies to
reduce body weight, and the acceptance was enhanced by
choosing a 2:1 allocation ratio assuming the IHM group
as the more popular one. Participants allocated to the
IHM group will have a free choice of different dietary
strategies. So for example, if someone does not wish to do
fasting, this is not to discourage him from participating in
the study since there are other options for an individual
dietary strategy.
Another issue is loss to follow-up which may lead to
biased estimates of intervention effects. While during the
first three months the high frequency of personal meet-
ings in the IHM group warrants a close relationship
between the study coaches and the participants there is
more need for careful following up the members of the
comparison group. We will remind them of the upcoming
examination visits by phone or mail and consider the indi-
vidual requirements to arrange feasible dates. We will
implement procedures to minimize the number of drop-
outs, and we will ask to tell us the reasons for withdrawal,
where possible. Nevertheless we anticipate an attrition
rate of about 10 %, and appropriate methods for handling
these drop-outs in the statistical analysis will be applied
(see ‘Statistical analysis’).
The potential effectiveness of an intervention is affected
by non-adherence to the intervention program. The IHM
program under investigation is requesting a high level of
active participation. During the whole study there are
sixteen personal meetings scheduled. Before enrollment to
the study all potential study participants are informed in
detail on the requirements. Although basically accepted it
has to be anticipated that especially for those participants
with a longer distance between their domicile and the
study centre not all appointments will be kept. We will
implement a simple score for compliance based on the
rate of participation and will use this for sensitivity ana-
lyses to check for potential association with effect sizes.
Although the process of IHM is clearly predefined a
broad range of individual health behavior actually prac-
ticed in the participants’ everyday life has to be antici-
pated. This variety of options is due to the individually
different life situations and thus will not automatically lead
to an exclusion from the program or the analysis of the
trial. Similarly, participants of the UC group who appar-
ently improve their lifestyle only by written advice need
not be excluded.
Expected benefit
This randomized study will contribute to the evidence of a
comprehensive lifestyle program which in the current
form has not yet been proved. The program with an active
duration of 12 months promises to achieve sustainable
effects in weight reduction. Based on a blended learning
concept and using web-based e-health tools the program
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might overcome the well-known experience of many diet
programs. Although knowing how lifestyle should be modi-
fied it proves to be hard to sustainably make an improved
health related behavior reality in everyday life. Furthermore,
the multicentre study will show whether comprehensive
lifestyle training can be implemented successfully in
local health and prophylaxis centres at various spas.
Additional files
Additional file 1: CONSORT 2010 checklist of information to include
when reporting a randomised trial*. (DOC 216 kb)
Additional file 2: CONSORT 2010 Flow diagram. (DOC 49 kb)
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